Regidor, P. and Sailer, M. 2024. Open prospective study to evaluate the efficacy of a new vaginal pessary containing 300mg tinidazole, 200mg tioconazole and 100mg lidocaine with a 3-day regime (Gynomax XL®) in the treatment of vaginal infections due to bacterial vaginosis, candidiasis an. REPRODUCTIVE ENDOCRINOLOGY. 71 (Mar. 2024), 117–126. DOI:https://doi.org/10.18370/2309-4117.2024.71.117-126.